蜱麻痹是一种经常被忽视的严重疾病，其特征是由喂食蜱产生的神经毒素引起的双侧上行弛缓性麻痹。我们旨在描述1993年至2016年不列颠哥伦比亚省（BC）BC疾病控制中心（BCCDC）记录的可疑蜱麻痹病例，并审查预防方法。诊断,和治疗考虑。
人口统计学，地理,我们回顾了1993年至2016年间向BCCDC公共卫生实验室(PHL)提交的疑似人和动物蜱麻痹患者的蜱虫测试申请表的临床数据.生成描述性统计数据来描述BC中的蜱麻痹病例，包括涉及的蜱物种，疾病的季节性，和地区差异。
从1993年到2016年，有56例疑似蜱麻痹病例，至少有一个蜱标本提交BCCDCPHL进行测试。43％和57％的病例涉及人类和动物，分别。大多数病例涉及Dermacentorandersoni蜱（48例或86％），发生在4月至6月之间（49例或88％）。在已知的滴答采集位置中，不列颠哥伦比亚省的内陆地区受到了不成比例的影响，25例(69%)蜱叮咬发生在该地区。
滴答麻痹是卑诗省的罕见病症。风险最高的地区是内部,特别是在春季和夏季。提高医护人员和公众对蜱麻痹的认识对于预防这种罕见疾病的发病率和死亡率至关重要。
Tick paralysis is a frequently overlooked severe disease characterized by bilateral ascending flaccid paralysis caused by a neurotoxin produced by feeding ticks. We aimed to characterize suspected tick paralysis cases documented at the BC Centre for Disease Control (BCCDC) in British Columbia (BC) from 1993 to 2016 and reviewed prevention, diagnosis, and treatment considerations.
Demographic, geographic, and clinical data from test requisition forms for ticks submitted to the BCCDC Public Health Laboratory (PHL) from patients across BC between 1993 and 2016 for suspected human and animal tick paralysis were reviewed. Descriptive statistics were generated to characterize tick paralysis cases in BC, including tick species implicated, seasonality of disease, and regional differences.
From 1993 to 2016, there were 56 cases of suspected tick paralysis with at least one tick specimen submitted for testing at the BCCDC PHL. Humans and animals were involved in 43% and 57% of cases, respectively. The majority of cases involved a Dermacentor andersoni tick (48 cases or 86%) and occurred between the months of April and June (49 cases or 88%). Among known locations of tick acquisition, the Interior region of BC was disproportionately affected, with 25 cases (69%) of tick bites occurring in that area.
Tick paralysis is a rare condition in BC. The region of highest risk is the Interior, particularly during the spring and summer months. Increasing awareness of tick paralysis among healthcare workers and the general public is paramount to preventing morbidity and mortality from this rare disease.
